Considerations on the use of sulphones and sulphonamides with a pyrimidine derivative.
D000328:Adult; D000655:Amodiaquine / Q000627:therapeutic use; D002648:Child; D003622:Dapsone / Q000627:therapeutic use*; D004338:Drug Combinations; D004352:Drug Resistance, Microbial; D006801:Humans; D008288:Malaria / Q000188:drug therapy*; D009073:Mozambique; D010963:Plasmodium falciparum; D010965:Plasmodium malariae; D011319:Primaquine / Q000627:therapeutic use; D011739:Pyrimethamine / Q000627:therapeutic use*; D013449:Sulfonamides / Q000627:therapeutic use*; D014295:Trimethoprim / Q000627:therapeutic use*
D004338:Drug Combinations; D013449:Sulfonamides; D000655:Amodiaquine; D003622:Dapsone; D014295:Trimethoprim; D011319:Primaquine; D011739:Pyrimethamine